UnitedHealth Revenue Grows by $14 billion in 2024
Jul 16, 2024 · For the second quarter of 2024, UnitedHealth’s earnings reached $98.9 billion, up almost $6 billion from the same quarter last year. The increase, company executives said, reflect growth at Optum and UnitedHealthcare. Second quarter adjusted earnings from operations were $8.7 billion and include business disruption from the Change Healthcare cyberattack.
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Nov 25, 2024 · CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
UnitedHealthcare Adds Deductibles to Medicare Part D for 2025
Oct 3, 2024 · UnitedHealthcare is adding deductibles to Part D prescriptions on certain formulary tiers as a result of plan design changes from the Inflation Reduction Act.
Aetna Updates MA and Drug Programs for Medicare in 2025
Oct 1, 2024 · In 2025, Aetna, the health insurance company of CVS Health, has added several new programs to Medicare for 2025. Aetna will launch new Chronic Condition Special Needs Plans (C-SNPs) in Illinois (Chicago) and Pennsylvania (Philadelphia and Pittsburgh).
Cancer’s Reign Over the Drug Development Pipeline Continues
Oct 18, 2024 · There have exceptions to their rule, such as glucagon-like peptide 1 (GLP-1) drugs and the COVID-19 vaccines. But drugs to treat cancer have been the dominant force in pharmaceutical innovation, clinical trials and drug expenditures for many years now, and nothing in Kaelyn C. Boss’ oncology drug pipeline talk yesterday at the 2024 Academy of Managed Care Pharmacy (AMCP) Nexus meeting ...
Study Estimates 5 Million People Could Benefit from Magic …
Dec 5, 2024 · Psilocybin-assisted therapy (PSIL-AT), which involves using the active ingredient from "magic mushrooms," could benefit roughly 5 million people currently receiving treatment for major depressive disorder (MDD) and treatment-resistant depression (TRD) if the FDA approves it, according to a new study from Emory University.. Psilocybin is currently FDA approved only for use in clinical trials to ...
Top 5 News Articles of 2024 - managedhealthcareexecutive.com
Dec 27, 2024 · UnitedHealthcare Adds Deductibles to Medicare Part D for 2025 UnitedHealthcare is adding deductibles to Part D prescriptions on certain formulary tiers as a result of plan design changes from the Inflation Reduction Act. Read more; Cataract Surgery: It Is More Than Just Your Vision That Improves Researchers have identified an association between cataract surgery and a lower risk of cognitive ...
How Capitation Contracts Benefit Providers, Payers and Patients
May 11, 2023 · The Covid-19 pandemic triggered a dramatic decline in patient volume that devastated revenues for provider organizations operating under the fee-for-service (FFS) reimbursement model. In response, more provider organizations have adopted alternative payment models (APM) built around financial incentives to efficiently deliver high-quality care.
Out-of-Pocket Costs for MS Medications Rise While They Drop for …
Dec 6, 2024 · The out-of-pocket cost for MS disease-modifying therapies jump by 217% going from $750 per year in 2012 to $2,378 per year in 2021.
Weighing GLP-1 coverage
Dec 5, 2024 · The impact on the healthcare system could be huge if costs are saved from a healthier population of people who are avoiding comorbidities. “Data are becoming available about the clinical benefits of GLP-1 therapies, but what is the net cumulative impact on outcomes and total cost of care?” asks Sanjula Jain, Ph.D., senior vice president of market strategy and chief research officer at ...